Maintenance Mode: Life After Reaching Your Goal on a GLP-1


Maintenance is a phase, not a finish line
Reaching your goal weight on a GLP-1 is not the end of treatment. It is the start of a new phase your physician manages with you. Obesity is now treated as a chronic, relapsing condition, much like high blood pressure. The medication helped you get here. Maintenance is an ongoing plan; it does not guarantee that weight will remain unchanged. Individual results vary.
Reaching a weight goal is a useful point to review care, not an automatic instruction to stop or reduce medicine. Appetite, symptoms, health conditions, and treatment preferences may change. Make room for those changes in a follow-up plan instead of treating one scale reading as a permanent result.2
What withdrawal research found
| Approach | What it looks like | Decided by |
|---|---|---|
| Continued treatment | Review the approved maintenance plan, response and tolerability | Your clinician3 |
| Dose review | Assess product-specific options and response; dose reduction is not automatic | Your physician |
| Stopping treatment | Regain occurred after medication and trial lifestyle support ended; a plan does not guarantee prevention | Discuss ongoing care with your clinician |
In the STEP 1 extension, the semaglutide group regained about two-thirds of its prior mean weight loss over 52 weeks after medication and the study lifestyle intervention ended; many cardiometabolic measures moved back toward baseline. The extension included 327 participants. Individual results vary.1
What does maintenance mode actually mean?
Maintenance means working with your clinician on an ongoing plan after weight stabilizes. The appropriate medicine and dose depend on the product, indication, response, and tolerability; reaching a goal does not automatically mean reducing the dose.
A useful follow-up covers what you are eating, whether activity feels manageable, any side effects, and what care costs. Bring practical barriers into the conversation. A plan that does not fit your daily life may need adjustment, but medication changes still need your prescriber's guidance.
Why does the weight come back after stopping?
Regain occurred in the STEP 1 extension after semaglutide and trial lifestyle support ended. This finding supports discussing ongoing care, but it cannot say what every person will regain or which alternative plan will work. The research should inform a conversation, not become a prediction or a reason for blame.1

Before changing treatment, ask which symptoms and measurements to track, when the next review will happen, and how to make contact earlier. Also ask about access and cost if your current prescription becomes difficult to obtain. Do not stretch doses, share medicines, or substitute a product based on an online suggestion.
How do I protect muscle while I maintain?
Weight loss may include lean tissue as well as fat. Lean mass is not the same as muscle strength or physical function. The joint nutrition advisory recommends assessing these areas and discussing appropriate nutrition and resistance activity. It does not establish a guaranteed muscle-loss percentage for you or promise that an exercise plan prevents all loss.2
Ask a clinician or dietitian to tailor food and protein goals to your needs. Kidney disease, frailty, low appetite, and difficulty with daily activities deserve specific assessment. Resistance activity should fit your abilities and medical conditions. Tell the team about new weakness or difficulty meeting nutritional needs instead of applying a generic high-protein target.2, 4
What about microdosing for maintenance?
An online maintenance schedule is not a substitute for the product label and a clinical plan. The appropriate medicine and dose depend on indication, response, and tolerability. Reaching a goal does not establish that a smaller or less frequent dose will maintain it. Ask the prescriber before any dose change.3
Lose weight with a plan made just for you
- Same-day doctor visits and prescriptions
- Semaglutide, tirzepatide & other GLP-1s
- FSA & HSA eligible with all plans

From price shown is the 12-month plan rate. Prices may vary.
Frequently asked questions
Was this helpful?
Keep reading
Weight Loss
Weight Loss
Weight Loss
Weight Loss
Weight Loss
Weight Loss

Sources
- Wilding JPH, et al. "Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension." Diabetes, Obesity and Metabolism, 2022. dom-pubs.onlinelibrary.wiley.com
- Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity. Joint advisory, July 2025. Accessed September 15, 2026. pubmed.ncbi.nlm.nih.gov
- DailyMed. Wegovy prescribing information, revised June 2026. Accessed September 15, 2026. dailymed.nlm.nih.gov
- NIDDK. Healthy Eating for Adults with Chronic Kidney Disease. Accessed September 15, 2026. niddk.nih.gov